The study of EPA's effects on coronary plaque inn patients with coronary heart diseases treated with PCI
Not Applicable
- Conditions
- coronary heart diseases
- Registration Number
- JPRN-UMIN000026693
- Lead Sponsor
- Kurume University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) prior taking EPA, 2) recent acute coronary syndrome (< 1 year), 3) renal insufficiency (serum creatinine > 2.0 mg / dL), 4) hepatic dysfunction (serum AST or ALT > 3-folds of standard value), 5) cancer, 6) autoimmune diseases, 7) impossibility in decision making 8) consideration as inadequate to participating in the study by attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method coronary plaque volume
- Secondary Outcome Measures
Name Time Method clinical events